State Street Corp Moderna, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Moderna, Inc. stock. As of the latest transaction made, State Street Corp holds 16,847,212 shares of MRNA stock, worth $664 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

16,847,212

Previous 15,023,936 12.14%

Holding current value

$664 Million

Previous $1.78 Billion 36.89%

% of portfolio

0.05%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $116 Million - $228 Million	1,823,276 Added 12.14%	16,847,212 $1.13 Billion
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $57.9 Million - $95.3 Million	571,901 Added 3.96%	15,023,936 $1.78 Billion
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $14.7 Million - $19.8 Million	-171,688 Reduced 1.17%	14,452,035 $1.54 Billion
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $46.7 Million - $70.2 Million	672,447 Added 4.82%	14,623,723 $1.45 Billion
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $26.6 Million - $34.9 Million	-275,951 Reduced 1.94%	13,951,276 $1.44 Billion
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $17.9 Million - $24.2 Million	150,872 Added 1.07%	14,227,227 $1.73 Billion
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $30.4 Million - $44.1 Million	-224,062 Reduced 1.57%	14,076,355 $2.16 Billion
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $24.3 Million - $43.2 Million	-205,649 Reduced 1.42%	14,300,417 $2.57 Billion
Q3 2022 Nov 15, 2022	SELL	$118.07 - $194.18 $30.8 Million - $50.6 Million	-260,514 Reduced 1.76%	14,506,066 $1.72 Billion
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $9.43 Million - $14.2 Million	-80,550 Reduced 0.54%	14,766,580 $2.11 Billion
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $2.05 Million - $3.82 Million	-16,240 Reduced 0.11%	14,847,130 $2.56 Billion
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $205 Million - $334 Million	905,789 Added 6.49%	14,863,370 $3.77 Billion
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $1.47 Billion - $3.21 Billion	6,632,005 Added 90.53%	13,957,581 $5.37 Billion
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $171 Million - $309 Million	1,316,702 Added 21.91%	7,325,576 $1.72 Billion
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $1.73 Million - $2.94 Million	-15,813 Reduced 0.26%	6,008,874 $787 Million
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $36.8 Million - $95 Million	-559,240 Reduced 8.49%	6,024,687 $629 Million
Q3 2020 Nov 10, 2020	BUY	$54.34 - $94.85 $30.3 Million - $52.8 Million	556,953 Added 9.24%	6,583,927 $466 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $15.7 Million - $42.4 Million	530,003 Added 9.64%	6,026,974 $387 Million
Q1 2020 May 11, 2020	BUY	$17.78 - $31.58 $97.7 Million - $174 Million	5,496,971 New	5,496,971 $165 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Moderna, Inc. Transaction History